A business in context

VIR research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-11 · 0001628280-26-056108

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-053549

  3. 8-K · Current report

    Report date 2026-08-05 · 0001628280-26-053351 · Items 2.02,9.01

  4. 8-K · Current report

    Report date 2026-07-20 · 0001628280-26-049499 · Items 5.02

  5. 4 · Ownership change

    Report date 2026-06-09 · 0001628280-26-042326

  6. 8-K · Current report

    Report date 2026-06-09 · 0001628280-26-042237 · Items 5.02

  7. 4 · Ownership change

    Report date 2026-06-01 · 0001628280-26-039943

  8. 4 · Ownership change

    Report date 2026-06-01 · 0001628280-26-039938

  9. 4 · Ownership change

    Report date 2026-05-27 · 0001628280-26-038966

  10. 4 · Ownership change

    Report date 2026-05-27 · 0001628280-26-038965

  11. 4 · Ownership change

    Report date 2026-05-27 · 0001628280-26-038964

  12. 4 · Ownership change

    Report date 2026-05-27 · 0001628280-26-038963

  13. 8-K · Current report

    Report date 2026-05-25 · 0001628280-26-038630 · Items 5.02,5.07

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-031471

  15. 8-K · Current report

    Report date 2026-05-06 · 0001628280-26-031273 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001628280-26-025379

  17. 8-K · Current report

    Report date 2026-04-07 · 0001193125-26-151209 · Items 5.02

  18. 8-K · Current report

    Report date 2026-03-04 · 0001193125-26-091447 · Items 5.02

  19. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-084367 · Items 8.01

  20. 8-K · Current report

    Report date 2026-02-25 · 0001193125-26-077416 · Items 1.01,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-010749

  22. 8-K · Current report

    Report date 2026-02-19 · 0001628280-26-010740 · Items 1.01,2.02,3.02,8.01,9.01

  23. 8-K · Current report

    Report date 2026-01-12 · 0001628280-26-001768 · Items 2.02,7.01,9.01

  24. 8-K · Current report

    Report date 2025-12-16 · 0001628280-25-057394 · Items 1.01,8.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-049694

  26. 8-K · Current report

    Report date 2025-11-05 · 0001628280-25-049561 · Items 2.02,9.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-038431

  28. 8-K · Current report

    Report date 2025-08-06 · 0001628280-25-038329 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2025-07-24 · 0001628280-25-035847 · Items 8.01,9.01

  30. 8-K · Current report

    Report date 2025-05-29 · 0001628280-25-028356 · Items 5.07

  31. 8-K · Current report

    Report date 2025-05-09 · 0001628280-25-024067 · Items 8.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-023291

  33. 8-K · Current report

    Report date 2025-05-07 · 0001628280-25-023175 · Items 2.02,9.01

  34. DEF 14A · Proxy statement

    Report date 2025-05-29 · 0001628280-25-018119

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-008245

  36. 8-K · Current report

    Report date 2025-02-26 · 0001628280-25-008163 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2025-01-24 · 0001628280-25-003073 · Items 5.02

  38. 8-K · Current report

    Report date 2025-01-08 · 0001193125-25-003214 · Items 7.01,8.01,9.01

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001628280-24-044995

  40. 8-K · Current report

    Report date 2024-10-31 · 0001628280-24-044563 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 5 transaction rows5SGrant / award: 16 transaction rows16AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

23 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-09
2026-06-10
Coughlin TimothyA · Grant / award
Acquired
Common Stock8000.00.0
2026-06-09
2026-06-10
Coughlin TimothyA · Grant / award
Acquired
Common Stock8000.00.0
2026-06-09
2026-06-10
Coughlin TimothyA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
16000.00.0
2026-06-09
2026-06-10
Coughlin TimothyA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
16000.00.0
2026-06-01
2026-06-02
Napolitano Janet
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3200.09.45
2026-06-01
2026-06-02
Sabatini Brent
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock379.09.45
2026-05-27
2026-05-28
Sigal Charles ElliottA · Grant / award
Acquired
Common Stock8000.00.0
2026-05-27
2026-05-28
Sigal Charles ElliottA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
16000.00.0
2026-05-27
2026-05-28
Napolitano JanetA · Grant / award
Acquired
Common Stock8000.00.0
2026-05-27
2026-05-28
Napolitano JanetA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
16000.00.0
2026-05-27
2026-05-28
MORE ROBERT JA · Grant / award
Acquired
Common Stock8000.00.0
2026-05-27
2026-05-28
MORE ROBERT JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
16000.00.0
2026-05-27
2026-05-28
Hatfield Jeffrey S.A · Grant / award
Acquired
Common Stock8000.00.0
2026-05-27
2026-05-28
Hatfield Jeffrey S.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
16000.00.0
2026-05-27
2026-05-28
Farid RamyA · Grant / award
Acquired
Common Stock8000.00.0
2026-05-27
2026-05-28
Farid RamyA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
16000.00.0
2026-05-27
2026-05-28
BISCHOFBERGER NORBERT WA · Grant / award
Acquired
Common Stock8000.00.0
2026-05-27
2026-05-28
BISCHOFBERGER NORBERT WA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
16000.00.0
2026-05-01
2026-05-04
SATO VICKI L
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock22000.010.05
2026-04-29
2026-04-30
De Backer MarianneJ · Other (see filing)
Disposed
Common Stock233532.00.0
2026-04-29
2026-04-30
De Backer MarianneJ · Other (see filing)
Acquired
Common Stock233532.00.0
2026-04-06
2026-04-07
De Backer Marianne
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock72559.09.16
2026-04-01
2026-04-02
SATO VICKI L
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock22000.09.07

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001706431Vir Biotechnology, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • VIR Biotechnology · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$74.20M$78.99M
2023-12-31$86.18M$94.44M
2022-12-31$1.62B$1.84B
2021-12-31$1.10B$1.35B
2020-12-31$76.37M$98.53M
2019-12-31$8.09M$10.57M
2018-12-31$10.67M$14.19M
2017-12-31$2.71M$3.69M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗